PHA Pharmagest Interactive SA

EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT

EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT

Villers-lès-Nancy, 20 January 2023 – 6:00 p.m. (CET)

PRESS RELEASE

H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT

WITH THE BROKERAGE FIRM GILBERT DUPONT

Under the liquidity agreement administered by the brokerage firm, Gilbert Dupont, on behalf of , liquidity account holdings at 30 December 2022 were as follows:

- Number of shares: 3,006

- Cash balance: €122,399.02

For the 2022 second half, a summary of total transactions is provided below:

PURCHASES29,847 shares€2,235,495.18756 transactions
SALES29,620 shares€2,208,567.87827 transactions

For information, liquidity account holdings were reported as follows:

in the half-year report of 30 June 2022:

- Number of shares: 2,676

- Cash balance: €157,148.62

when the liquidity agreement was first implemented:

- Number of shares: 2,219

- Cash balance: €50,000.00

This liquidity agreement is executed in accordance with Decision No. 2021-01 of 22 June 2021 of the Autorité des Marchés Financiers (“AMF”) establishing accepted market practices in relation to the renewal of liquidity agreements for shares, which provisions replace the previous Decision No. 2018-01.

About

With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment A

Included in the Euronext Tech Leaders segment and the European Rising Tech label

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusion

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).

ISIN: FR0012882389 - Ticker Code: EQS

For all the latest news on Equasens Group go to

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Frédérique SCHMIDT

Tel. +33 (0)3 83 15 90 67 –

Media Relations:

FIN’EXTENSO - Isabelle APRILE

+33 (0)1 39 97 61 22 -   

APPENDIX

 PurchasesSales
 Number of transactionsNumber of sharesNumber of transactionsNumber of sharesNumber of transactionsNumber of shares
TOTAL75629 8472 235 495,1882729 6202 208 567,87
01/07/20228190145001937929232,8
04/07/20222038529712,99819114870,21
05/07/2022029822809,19013410416,2
06/07/2022021416301,41030423415,11
07/07/20220251937,5031624759,01
08/07/202251108684,011729723621,6
11/07/2022414111239,51116713395,3
12/07/20221036529332,21137930644,08
13/07/20221846637308,61721517069,3
14/07/2022021717142,3901007950
15/07/2022013610724,29015812447,3
18/07/2022020016012,4040532405,91
19/07/2022039831387,71036828987,8
20/07/2022025820612,6037629847,9
21/07/20220887216028723204,61
22/07/2022025921305,81014011554,4
25/07/2022017214172,09021517860,01
26/07/2022030825758,59027122704
27/07/2022039232737,290857123
28/07/2022519215990,61222218628,8
29/07/20221218815866,091628924517,89
01/08/20222241434873,7423520351
02/08/2022040733506,40473924,5
03/08/2022026221495,11051943186,92
04/08/2022016013482,8018215415
05/08/2022050041699,9013011042,01
08/08/2022015012174019616030,6
09/08/2022029323984,39021417728,4
10/08/2022021117173,8027122267,5
11/08/2022021217520,1015813124,7
12/08/2022024019702,61013711285,8
15/08/2022018415265,01046439191,99
16/08/2022018715552027723183,4
17/08/2022022618784,19026722291,59
18/08/2022032626970,11015012552
19/08/2022019015620,3023019008,01
22/08/2022026821750,8000
23/08/2022019915885,79014811863,61
24/08/202201088615,6035528709,6
25/08/20220685564,5019916422,69
26/08/2022030424780,99000
29/08/2022024019148,69000
30/08/2022019615334,101068359,2
31/08/2022024619143,4018314289,3
01/09/2022013810561,60175,8
02/09/20220161209,6036628427
05/09/2022021616701,1000
06/09/2022019515080,7025019383,7
07/09/202201098411,6024018680,21
08/09/2022000036829109,5
09/09/202201239801,4017013625,01
12/09/2022018514737,51024519643,51
13/09/2022041732995,7901219691,89
14/09/2022028421898,5901078305,7
15/09/2022019714893,1000
16/09/2022036226569,79037327493,38
19/09/2022015311022016912198,79
20/09/2022022015831,901158273,5
21/09/20220614342,7035125292,71
22/09/2022032223037,720251802,5
23/09/2022029820766,49024617609,69
26/09/2022029920359,9901389521,7
27/09/2022022314728,1901419390,9
28/09/2022019812535,50503117,5
29/09/202201579516,1901519152,09
30/09/202201317804,8043426316,41
03/10/2022026315662,81028917325,41
04/10/202201006040041425705,59
05/10/20222437023418,4881529801,7
06/10/2022817811140,0181438991,2
07/10/2022029418332,61016810598,1
10/10/20222638323460,592804944
11/10/2022021112431,8019011265,1
12/10/20221621612642,22224114144,8
13/10/2022711064702336821942,11
14/10/20222321962,91628117406,91
17/10/20224976035,41725015784,6
18/10/20220001930919993,81
19/10/2022028618456,3019212442
20/10/20228785021,6919612717,4
21/10/20220372393,9026817573,7
24/10/20221927918274,811833021722,61
25/10/20221524116185,11837525017,79
26/10/20221322615349,312348232948,89
27/10/20221929420310,112941528729,41
28/10/20222543730203,521233523156,1
31/10/20221238727414,312242029529,32
01/11/20221122616354,63041229764,98
02/11/20222944332223,912534525197,7
03/11/2022046833843,28035025315,19
04/11/20222862044549,293550235806,41
07/11/2022017212147,4026418776,21
08/11/2022034224217,19040829097,58
09/11/20221533023378,09101067569,4
10/11/20221737225957,92156039946,98
11/11/20227705270,32635126630,69
14/11/20221033525897,912539430663,8
15/11/202223400308753282170
16/11/20222336727798,712221694
17/11/20221123117090,1121259294,2
18/11/202261007383,52731623684,48
21/11/2022023017258,6023317558,6
22/11/20221221665,41722817492,3
23/11/20221832024550,91816512696,5
24/11/20221736928185,511020815972,4
25/11/20225886705,61928121798,21
28/11/2022028822039,80171303,9
29/11/2022019514862027420975,3
30/11/20220806122,5037829351,21
01/12/20222534926908,811113810693,61
02/12/2022026420137,2101088277,9
05/12/2022818013725,22031323934,52
06/12/2022041931497,190211543,5
07/12/20221219714356,21227219869,3
08/12/20221416011679,51613710054,5
09/12/20223755487,52226919881,2
12/12/2022019014046,21031723560,3
13/12/20221122116455,591628521401,59
14/12/20221514911129,5916512385
15/12/20221419714699,1414010443,01
16/12/20222033524648,34805932
19/12/20222131622762,817805819,6
20/12/2022015010733,401339537,7
21/12/202215035802831022517,69
22/12/202291329720,11419714609,5
23/12/20221916311976,710705152,7
26/12/2022000000
27/12/20220997360,1028821411,01
28/12/20221725919198,895614483,5
29/12/202296547752140830327,21
30/12/20223539329448,79713610237,4

Attachment



EN
20/01/2023

Underlying

PHAPharmagest Interactive SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

Arnaud Riverain
  • Arnaud Riverain
PHA Pharmagest Inte...

EQUASENS (EQS) - RN 2023 : 2025, changement de braquet / Achat - Obj. ...

Résultats en ligne avec nos attentes Marge Ebitda 30,4% (attendu 30,5%), marge opérationnelle courante 25,4% (25,3% attendu, marge nette 22,2% (20,8% attendu) Gearing en légère amélioration -29,7% vs -28,5% en 2022 (-38,5% attendu) Dividende proposé 1,25 € +9,2% Objectif 2025 : croissance à 2 chiffres

PHA PHARMAGEST INTERACTIVE SA
04/02/24 April 2, 2024 4 FR
 PRESS RELEASE
Free
PHA Pharmagest Inte...

Equasens: 2023 Annual Results

Equasens: 2023 Annual Results Villers-lès-Nancy, 29 March 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 Annual Results Annual results impacted by the overperformance at the end of 2022 and early 2023 driven by solutions introduced under the Ségur programme as well as an unfavourable economic climate Revenue: €219.7m, +2.6% Net Profit: €48.9m, +0.4% Net Profit attributable to Group shareholders: €47.0m, +1.4% The Current Operating Margin remains at a high level (25.4%)Dividend proposal for FY 2023: €1.25 per share (+9.2%) In €m202120222023Change2023/2022Revenue193.1214.1219.7+2.6%Current O...

March 29, 2024 1 EN
 PRESS RELEASE
Free
PHA Pharmagest Inte...

EQUASENS : Résultats Annuels 2023

EQUASENS : Résultats Annuels 2023 Villers-lès-Nancy, le 29 mars 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats Annuels 2023 Résultats impactés par une surperformance fin 2022 et début 2023 liée au déploiement des versions SEGUR et une conjoncture défavorable Chiffre d’affaires : +2,6% à 219,7 M€ Résultat Net : +0,4% à 48,9 M€ Résultat Net Part du Groupe : +1,4% à 47,0 M€ Rentabilité ROC/CA maintenue à un niveau élevé (25,4%)Dividende proposé au titre de l’exercice 2023 : 1,25€ par action (+9,2%) En millions d'euros202120222023Variation2023/2022Chiffre d’Affaires193,1214,1219,7+ 2,6 ...

March 29, 2024 1 EN
 PRESS RELEASE
Free
PHA Pharmagest Inte...

EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE

EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE Villers-lès-Nancy, le 07 février 2024 - 18h30 (CET) COMMUNIQUE DE PRESSE BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITECONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT Au titre du contrat de liquidité confié par la société à la Société de Bourse Gilbert Dupont, à la date du 29 décembre 2023, les moyens suivants figuraient au compte de liquidité : -        Nombre d’actions : 3 468-        Solde en espèces : 89 589,07 € Au cours du 2ème semestre 2023, il a été négocié un total de : ACHAT42 199 titres2 945 478,15 €2 408 t...

February 7, 2024 1 EN
Arnaud Riverain
  • Arnaud Riverain
PHA Pharmagest Inte...

EQUASENS (EQS) - CA 2023 : Le Ségur, élément perturbateur / Achat - Ob...

CA Groupe 219,7 M€ +2,6% vs 227 M€ attendus (+3,3% pc & hors Ségur) Apport acquisitions +2,9 M€ Apport Ségur +3,2 M€ vs +7,3 M€ en 2022

PHA PHARMAGEST INTERACTIVE SA
02/07/24 February 7, 2024 4 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch